NIH, National Cancer Institute, Division of Cancer Treatment and Diagnosis (DCTD) NIH - National Institutes of Health National Cancer Institute DCTD - Division of Cancer Treatment and Diagnosis

Efficient Detection of BRAF Mutation in Plasma of Patients after Long-term Storage of Blood in Cell-Free DNA Blood Collection Tubes.

Author(s): Denis MG, Knol AC, Théoleyre S, Vallée A, Dréno B

Publication: Clin Chem, 2015, Vol. 61, Page 886-8

PubMed ID: 25896990 PubMed Review Paper? No

Purpose of Paper

This paper investigated the effects of delayed centrifugation of blood, tube type, and shipping on the detection of B-Raf proto-oncogene, serine/threonine kinase (BRAF) mutations in plasma.

Conclusion of Paper

Storage of uncentrifuged blood in EDTA tubes resulted in a decrease in the percentage of mutated DNA, but storage in BCT tubes did not affect the quantification of mutated DNA in eight of ten patients. Further, the quantification cycle values were comparable between blood that was processed immediately and blood shipped in BCT tubes and processed 4-6 days after collection.

Studies

  1. Study Purpose

    This study investigated the effects of delayed centrifugation of blood, tube type, and shipping on the detection of BRAF mutations in plasma. To investigate the effects of tube type, blood was drawn from ten melanoma patients with a known V600E or V600K BRAF mutation into K3EDTA and BCT tubes. Blood was stored at room temperature and aliquots were removed after 2 h, 4 days, 7 days, and 10 days. Plasma was obtained by centrifugation at 2000 x g for 10 min. To investigate the effect of shipping, blood was drawn from six patients into BCT tubes, an aliquot was removed and processed immediately, and the remainder of the specimen was sent by mail at ambient temperatures. Specimens were then processed 4-6 days after collection. DNA was extracted using the PureLink Virus Kit and mutations were detected using the Therascreen BRAF RGQ kit.

    Summary of Findings:

    Plasma obtained from blood stored uncentrifuged in EDTA tubes at room temperature had a decrease in the control quantification cycle value and comparable mutation specific quantification cycle values. Consequently, the amount of normal DNA in plasma was 6-, 44-, and 110-fold higher when uncentrifuged blood was stored at room temperature in EDTA tubes for 4, 7, and 10 days, respectively than when blood was centrifuged after 2 h. In contrast, the quantification cycle value was not affected in 8 of 10 specimens when uncentrifuged blood was stored in BCT tubes at room temperature, but smaller increases in normal DNA were observed in the remaining two specimens when compared to those stored in EDTA tubes. The quantification cycle values were comparable between blood that was processed immediately and blood shipped in BCT tubes and processed 4-6 days after collection.

    Biospecimens
    Preservative Types
    • None (Fresh)
    • Streck/BCT
    Diagnoses:
    • Neoplastic - Melanoma
    Platform:
    AnalyteTechnology Platform
    DNA Real-time qPCR
    Pre-analytical Factors:
    ClassificationPre-analytical FactorValue(s)
    Biospecimen Acquisition Type of collection container/solution EDTA tube
    BCT tube
    Biospecimen Preservation Type of fixation/preservation Blood collection tube additive
    EDTA
    Real-time qPCR Specific Targeted nucleic acid Wildtype BRAF
    Mutated BRAF
    Storage Between site transportation method Not transported
    Mailed
    Storage Time at room temperature 2 h
    4 days
    7 days
    10 days

You Recently Viewed  

News and Announcements

  • Most Downloaded SOPs in 2024

  • New Articles on the GTEx Project are Now FREELY Available!

  • Just Published!

  • More...